UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 10-Q
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 
  
For the quarterly period ended: September 30, 2026  
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 
For the transition period from to
Commission file number: 001-07626
 
Sensient Technologies Corporation
(Exact name of registrant as specified in its charter)
 
  
Wisconsin 39-0561070
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
 
777 EAST WISCONSIN AVENUE, MILWAUKEE, WISCONSIN 53202-5304
(Address of principal executive offices)
 
Registrant's telephone number, including area code: (414) 271‑6755
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.10 per share
SXT
New York Stock Exchange LLC
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. Yes ☒ No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    
 
Large Accelerated Filer  ☒
Accelerated Filer ☐
Non-Accelerated Filer  ☐
 
Smaller Reporting Company ☐
Emerging Growth Company ☐
  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐              No ☒
 
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
 
Class
 
Outstanding at October 22, 2026
Common Stock, par value $0.10 per share
 
42,561,738
 
1
Index
 
SENSIENT TECHNOLOGIES CORPORATION
INDEX
 
    
    
Page No.
      
PART I. FINANCIAL INFORMATION:
  
      
 
Item 1.
  
  
1
      
  
2
      
  
3
      
  
4
      
  
5
      
  
6
      
 Item 2.
15
      
 
Item 3.
21
      
 
Item 4.
21
      
PART II. OTHER INFORMATION:
  
      
 
Item 1.
21
      
 
Item 1A.
21
      
 
Item 2.
22
      
 
Item 5.
22
      
 
Item 6.
22
      
  
23
      
  
24
 
2
Index
 
PART I.
 
FINANCIAL INFORMATION
ITEM 1.
 
FINANCIAL STATEMENTS
 
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF EARNINGS
(In thousands except per share amounts)
(Unaudited)
 
                 
                     
    Three Months     Nine Months  
    Ended September 30,     Ended September 30,  
    2026     2025     2026     2025  
                     
Revenue
 $455,841   $412,109   $1,353,756   $1,218,664 
Cost of products sold
  290,893    270,767    863,321    802,713 
Selling and administrative expenses
  92,499    83,636    274,558    247,009 
Operating income
  72,449    57,706    215,877    168,942 
Interest expense
  8,345    7,328    24,421    22,060 
Earnings before income taxes
  64,104    50,378    191,456    146,882 
Income taxes
  15,760    13,422    47,583    37,877 
Net earnings
 $48,344   $36,956   $143,873   $109,005 
                     
Weighted average number of common shares outstanding:
                   
Basic
  42,353    42,248    42,333    42,231 
Diluted
  42,831    42,665    42,753    42,570 
                     
Earnings per common share:
                   
Basic
 $1.14   $0.87   $3.40   $2.58 
Diluted
 $1.13   $0.87   $3.37   $2.56 
                     
Dividends declared and paid per common share
 $0.41   $0.41   $1.23   $1.23 
 
See accompanying notes to consolidated condensed financial statements.
 
1
 
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
 
                     
    Three Months     Nine Months  
    Ended September 30,     Ended September 30,  
    2026     2025     2026     2025  
                     
Comprehensive income
 $39,863   $36,591   $134,554   $162,000 
 
See accompanying notes to consolidated condensed financial statements.
 
2
 
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)
 
         
    September 30,       
    2026     December 31,  
Assets
  (Unaudited)     2025  
           
Current Assets:
         
Cash and cash equivalents
 $42,625   $36,533 
Trade accounts receivable
  373,755    305,380 
Inventories
  791,096    678,220 
Prepaid expenses and other current assets
  75,168    59,717 
Fixed assets held for sale
   -     1,598 
           
Total current assets
  1,282,644    1,081,448 
           
Other assets
  104,720    102,362 
Deferred tax assets
  39,022    71,204 
Intangible assets, net
  9,429    10,121 
Goodwill
  433,588    439,706 
Property, Plant, and Equipment:
         
Land
  34,898    34,898 
Buildings
  369,017    366,797 
Machinery and equipment
  877,289    858,762 
Construction in progress
  143,635    78,492 
    1,424,839    1,338,949 
Less accumulated depreciation
  (818,410)    (799,653) 
    606,429    539,296 
           
Total assets
 $2,475,832   $2,244,137 
           
Liabilities and Shareholders’ Equity
         
           
Current Liabilities:
         
Trade accounts payable
 $187,501   $138,344 
Accrued salaries, wages, and withholdings from employees
  49,674    43,988 
Other accrued expenses
  71,598    65,652 
Income taxes
  13,976    15,247 
Short-term borrowings
  257    352 
           
Total current liabilities
  323,006    263,583 
           
Deferred tax liabilities
  13,434    13,651 
Other liabilities
  38,786    40,112 
Accrued employee and retiree benefits
  23,733    24,045 
Long-term debt
  790,148    709,232 
Shareholders’ Equity:
         
Common stock
  5,396    5,396 
Additional paid‑in capital
  130,113    123,668 
Earnings reinvested in the business
  1,938,572    1,847,014 
Treasury stock, at cost
  (607,784)    (612,311) 
Accumulated other comprehensive loss
  (179,572)    (170,253) 
           
Total shareholders’ equity
  1,286,725    1,193,514 
           
Total liabilities and shareholders’ equity
 $2,475,832   $2,244,137 
 
See accompanying notes to consolidated condensed financial statements.
 
3
 
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
         
           
    Nine Months  
    Ended September 30,  
    2026     2025  
           
Cash flows from operating activities:          
Net earnings  $143,873   $109,005 
Adjustments to arrive at net cash provided by operating activities:          
Depreciation and amortization   47,680    45,890 
Share-based compensation expense   13,762    10,584 
Net (gain) loss on assets   (39)    166 
Portfolio Optimization Plan costs    -     2,107 
Deferred income taxes   17,090    3,899 
Changes in operating assets and liabilities:          
Trade accounts receivable   (71,188)    (19,716) 
Inventories   (117,230)    (35,609) 
Prepaid expenses and other assets   (10,299)    (9,160) 
Accounts payable and other accrued expenses   45,089    (10,973) 
Accrued salaries, wages, and withholdings from employees   5,962    (9,781) 
Income taxes   (1,139)    (5,076) 
Other liabilities   1,759    1,927 
           
Net cash provided by operating activities   75,320    83,263 
           
Cash flows from investing activities:          
Acquisition of property, plant, and equipment   (105,775)    (57,788) 
Proceeds from sale of assets   2,032    397 
Acquisition of new business    -     (4,867) 
Other investing activities   (536)    1,260 
           
Net cash used in investing activities   (104,279)    (60,998) 
           
Cash flows from financing activities:          
Proceeds from additional borrowings   180,065    125,619 
Debt payments   (88,310)    (84,662) 
Dividends paid   (52,315)    (52,196) 
Other financing activities   (4,411)    (2,648) 
           
Net cash provided by (used in) financing activities   35,029    (13,887) 
           
Effect of exchange rate changes on cash and cash equivalents   22    7,665 
           
Net increase in cash and cash equivalents   6,092    16,043 
Cash and cash equivalents at beginning of period   36,533    26,626 
           
Cash and cash equivalents at end of period  $42,625   $42,669 
 
See accompanying notes to consolidated condensed financial statements.
 
4
 
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In thousands, except share and per share amounts)
(Unaudited)
 
                                    
Three Months Ended September 30, 2026


Common
Stock 		   
Additional
Paid-In
Capital 		    Earnings
Reinvested
in the
Business 		  Treasury Stock   Accumulated
Other
Comprehensive
(Loss) Income		   

Total
Equity 		 
 
Shares 		   
Amount 		 
Balances at June 30, 2026
 $5,396   $125,863   $1,907,676    11,601,956   $(607,916)   $(171,091)   $1,259,928 
Net earnings
   -      -     48,344     -      -      -     48,344 
Other comprehensive loss
   -      -      -      -      -     (8,481)    (8,481) 
Cash dividends paid – $0.41 per share
   -      -     (17,448)     -      -      -     (17,448) 
Share-based compensation
   -     4,382     -      -      -      -     4,382 
Non-vested stock issued upon vesting
   -     (132)     -     (2,521)    132     -      -  
Balances at September 30, 2026
 $5,396   $130,113   $1,938,572    11,599,435   $(607,784)   $(179,572)   $1,286,725 
 
                             
Three Months Ended September 30, 2025                                   
Balances at June 30, 2025
 $5,396   $119,114   $1,819,488    11,706,566   $(613,398)   $(173,479)   $1,157,121 
Net earnings
   -      -     36,956     -      -      -     36,956 
Other comprehensive loss
   -      -      -      -      -     (365)    (365) 
Cash dividends paid – $0.41 per share
   -      -     (17,496)     -      -      -     (17,496) 
Share-based compensation
   -     3,945     -      -      -      -     3,945 
Balances at September 30, 2025
 $5,396   $123,059   $1,838,948    11,706,566   $(613,398)   $(173,844)   $1,180,161 
 
                             
Nine Months Ended September 30, 2026                                   
Balances at December 31, 2025
 $5,396   $123,668   $1,847,014    11,685,819   $(612,311)   $(170,253)   $1,193,514 
Net earnings
   -      -     143,873     -      -      -     143,873 
Other comprehensive loss
   -      -      -      -      -     (9,319)    (9,319) 
Cash dividends paid – $1.23 per share
   -      -     (52,315)     -      -      -     (52,315) 
Share-based compensation
   -     13,762     -      -      -      -     13,762 
Non-vested stock issued upon vesting
   -     (5,975)     -     (114,036)    5,975     -      -  
Benefit plans
   -     729     -     (17,031)    892     -     1,621 
Other
   -     (2,071)     -     44,683    (2,340)     -     (4,411) 
Balances at September 30, 2026
 $5,396   $130,113   $1,938,572    11,599,435   $(607,784)   $(179,572)   $1,286,725 
 
                             
Nine Months Ended September 30, 2025                                   
Balances at December 31, 2024  $5,396   $117,500   $1,782,139    11,779,321   $(617,210)   $(226,839)   $1,060,986 
Net earnings    -      -     109,005     -      -      -     109,005 
Other comprehensive income    -      -      -      -      -     52,995    52,995 
Cash dividends paid – $1.23 per share    -      -     (52,196)     -      -      -     (52,196) 
Share-based compensation    -     10,584     -      -      -      -     10,584 
Non-vested stock issued upon vesting    -     (4,606)     -     (87,916)    4,606     -      -  
Benefit plans    -     394     -     (19,899)    1,043     -     1,437 
Other    -     (813)     -     35,060    (1,837)     -     (2,650) 
Balances at September 30, 2025  $5,396   $123,059   $1,838,948    11,706,566   $(613,398)   $(173,844)   $1,180,161 
 
See accompanying notes to consolidated condensed financial statements.
 
5
 
SENSIENT TECHNOLOGIES CORPORATION
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(Unaudited)
 
1.
Accounting Policies
 
In the opinion of Sensient Technologies Corporation (the Company), the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) that are necessary to present fairly the financial position of the Company as of September 30, 2026, and the results of operations, comprehensive income, and shareholders’ equity for the three and nine months ended September 30, 2026 and 2025, and cash flows for the nine months ended September 30, 2026 and 2025. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full year.
 
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Expenses are charged to operations in the period incurred.
 
Recently Adopted Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. This ASU also requires the Company to disaggregate its income taxes paid disclosure by federal, state, and foreign taxes, with further disaggregation required for significant individual jurisdictions. This ASU is effective for fiscal years beginning after December 15, 2024. The Company adopted this ASU in the fourth quarter of 2025 using a prospective transition method. The Company updated its annual disclosures as a result of adopting this ASU, and the adoption did not have a material impact on the Company’s consolidated financial statements.
 
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) – Disaggregation of Income Statement Expenses, which will require the Company to disclose disaggregated information about certain income statement expense line items. This ASU is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and its related disclosures.
 
Please refer to the notes in the Company’s annual consolidated financial statements for the year ended December 31, 2025, for additional details of the Company’s financial condition and a description of the Company’s accounting policies, which have been continued without change.
 
2.     Acquisition
 
On February 14, 2025, the Company acquired Biolie SAS, a natural color extraction business located in France. The Company paid $4.9 million in cash for this acquisition, which is net of $0.2 million in debt assumed. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $0.3 million, with the remaining $4.6 million allocated to goodwill. This business is part of the Color segment.
 
3.    Portfolio Optimization Plan
 
During the fourth quarter of 2023, the Board of Directors of the Company approved a plan to undertake an effort to optimize certain production facilities and improve efficiencies within the Company (Portfolio Optimization Plan). As part of the Portfolio Optimization Plan, in the Flavors & Extracts segment, the Company evaluated the closure of its manufacturing facility in Felinfach, Wales, United Kingdom, the closure of its sales office in Granada, Spain, and the centralization and elimination of certain selling and administrative positions. In addition, in the Color segment, the Company evaluated the closure of a manufacturing facility in Delta, British Columbia, Canada, the closure of a sales office in Argentina, and centralizing and eliminating certain production positions and selling and administrative positions. The Company reports all costs associated with the Portfolio Optimization Plan in the Corporate & Other segment.
 
6
 
The Company’s Felinfach site was shut down in May 2025, and all production activities have been transferred to other locations. The Company began marketing the Felinfach site for sale in June 2025, at which point the held for sale criteria were met. These are the sole assets recorded in Fixed assets held for sale on the Company’s Consolidated Balance Sheet at December 31, 2025. The Company sold the land and building assets in February 2026 for approximately $2.0 million, resulting in a $0.4 million gain recognized in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings during the three months ended March 31, 2026. There were no costs associated with the Portfolio Optimization Plan recognized during the three or nine months ended September 30, 2026. The Company has completed all actions contemplated under the Portfolio Optimization Plan.
 
The total cost of the Portfolio Optimization Plan was approximately $50 million, primarily related to non-cash impairment charges and employee separation costs. We anticipate that the Portfolio Optimization Plan will reduce annual operating costs by approximately $8 million, with the full benefit expected to be achieved beginning in 2026. The Company reduced headcount by approximately 100 positions, primarily in the Flavors & Extracts and Color segments, related to certain production and selling and administrative positions.
 
The following table summarizes the Portfolio Optimization Plan expenses by segment for the three months ended September 30, 2025:
 
             
(In thousands)
  Flavors &
Extracts 		   
Color 		   
Consolidated 		 
Non-cash impairment charges – Selling and administrative expenses
 $584   $ -    $584 
Non-cash charges – Cost of products sold
  249      -     249 
Employee separation – Selling and administrative expenses
  16          -     16 
Other production costs – Cost of products sold
  400       -     400 
Other costs – Selling and administrative expenses (1)
   1,955    119    2,074 
Total
 $3,204   $119   $3,323 
 
(1)
Other costs include professional services, decommissioning costs, and other related costs.
 
The following table summarizes the Portfolio Optimization Plan expenses by segment for the nine months ended September 30, 2025:
 
 
(In thousands)
  Flavors &
Extracts 		      Color     Corporate &
Other 		      Consolidated  
Non-cash impairment charges – Selling and administrative expenses
$701  $                -   $                -   $701 
Non-cash charges – Cost of products sold
  1,430     -                     -     1,430 
Employee separation – Selling and administrative expenses
  496    8       -     504 
Other production costs – Cost of products sold
  2,822         -            -     2,822 
Other costs – Selling and administrative expenses (1)
   3,683    221    165    4,069 
Total
 $9,132   $229   $165   $9,526 
 
(1)
Other costs include professional services, decommissioning costs, and other related costs.
 
4.
Trade Accounts Receivable
 
Trade accounts receivables are recorded at their face amount, less an allowance for expected losses on doubtful accounts. The allowance for doubtful accounts is calculated based on customer-specific analysis and an aging methodology using historical loss information. The Company believes historical loss information is a reasonable basis for expected credit losses as the Company’s historical credit loss experience correlates with its customer delinquency status. This information is also adjusted for any known current economic conditions. Forecasted economic conditions have not had a significant impact on the current credit loss estimate due to the short-term nature of the Company’s customer receivables; however, the Company will continue to monitor and evaluate the rapidly changing economic conditions. Additionally, as the Company only has one portfolio segment, there are not different risks between portfolios. Specific accounts are written off against the allowance for doubtful accounts when the receivable is deemed no longer collectible.
 
7
 
The following table summarizes the changes in the allowance for doubtful accounts during the three and nine month periods ended September 30, 2026 and 2025:
 
     
(In thousands)
Three Months Ended September 30, 2026
  Allowance for
Doubtful Accounts 		 
Balance at June 30, 2026
 $5,118 
Provision for expected credit losses
  35 
Accounts written off
  (111) 
Translation and other activity
  (20) 
Balance at September 30, 2026
 $5,022 
 
     
(In thousands)
Three Months Ended September 30, 2025
  Allowance for
Doubtful Accounts 		 
Balance at June 30, 2025
 $5,612 
Provision for expected credit losses
  120 
Accounts written off
  (344) 
Translation and other activity
  1 
Balance at September 30, 2025
 $5,389 
 
     
(In thousands)
Nine Months Ended September 30, 2026
  Allowance for
Doubtful Accounts 		 
Balance at December 31, 2025
 $5,128 
Provision for expected credit losses
  532 
Accounts written off
  (612) 
Translation and other activity
  (26) 
Balance at September 30, 2026
 $5,022 
 
     
(In thousands)
Nine Months Ended September 30, 2025
  Allowance for
Doubtful Accounts 		 
Balance at December 31, 2024
 $5,023 
Provision for expected credit losses
  864 
Accounts written off
  (809) 
Translation and other activity
  311 
Balance at September 30, 2025
 $5,389 
 
5.
Inventories
 
At September 30, 2026, and December 31, 2025, inventories included finished and in-process products totaling $551.9 million and $491.4 million, respectively, and raw materials and supplies of $239.2 million and $186.8 million, respectively.
 
6.
Debt
 
On March 27, 2026, the Company issued €65 million of Euro-denominated senior notes under the Amended and Restated Consolidated Note Purchase and Master Note Agreement, maturing in March 2030 and bearing an interest rate of 4.00%. The proceeds were used to repay a portion of the Company’s existing revolving credit facility.
 
On June 18, 2026, the Company entered into a Credit Agreement (Credit Agreement) with CoBank, ACB, and the lenders party thereto from time to time. The Credit Agreement provides for an unsecured delayed-draw term loan credit facility (Term Loan) in the aggregate principal amount of up to $400 million, which is to be drawn in up to five advances over fifteen months following the closing date. All amounts owing under the Term Loan will be due five years from the closing date. Proceeds from the Credit Agreement will be used to refinance existing indebtedness and for working capital and other general corporate purposes. There was $100 million outstanding on the Term Loan as of September 30, 2026.
 
On August 31, 2026, the Company entered into Omnibus Amendment No. 1 (Receivables Amendment) to the Receivables Purchase Agreement, dated October 3, 2016. The Receivables Amendment amends the Receivables Purchase Agreement to, among other things, (i) add PNC Bank, National Association as a purchaser and the administrative agent under the Receivables Securitization Program, (ii) increase the facility limit from $105 million to $115 million, and (iii) extend the termination date of the Receivables Securitization Program from August 31, 2026 to August 30, 2027. The amount was fully drawn as of September 30, 2026.
 
8
 
7.
Fair Value
 
Accounting Standards Codification 820, Fair Value Measurement, defines fair value for financial assets and liabilities, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. The carrying values of the Company’s cash and cash equivalents, trade accounts receivable, trade accounts payable, accrued expenses, and short-term borrowings were approximately the same as the fair values as of September 30, 2026 and December 31, 2025. The net fair value of the forward exchange contracts based on current pricing obtained for comparable derivative products (Level 2 inputs) was an asset of $0.4 million and $0.3 million as of September 30, 2026 and December 31, 2025, respectively. The fair value of the Company’s long-term debt, including the portions of long-term debt classified as Short-term borrowings on the Company’s Consolidated Balance Sheets, is estimated using discounted cash flows based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements (Level 2 inputs). The carrying value of the long-term debt at September 30, 2026 and December 31, 2025, was $790.3 million and $709.5 million, respectively. The fair value of the long-term debt at September 30, 2026 and December 31, 2025, was $791.4 million and $720.9 million, respectively.
 
8.
Segment Information
 
The Company evaluates performance based on operating income before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders); restructuring and other charges, including Portfolio Optimization Plan costs; interest expense; and income taxes (segment operating income). Total revenue and segment operating income by business segment and geographic region include both sales to customers, as reported in the Company’s Consolidated Statements of Earnings, and intersegment sales, which are accounted for at prices that approximate market prices and are eliminated in consolidation.
 
Assets by business segment and geographic region are those assets used in the Company’s operations in each segment and geographic region. Segment assets reflect the allocation of goodwill to each segment. Corporate & Other assets consist primarily of accounts receivables from the securitization program, investments, deferred tax assets, and fixed assets.
 
The Company determines its operating segments based on information utilized by its chief operating decision maker (CODM) to allocate resources and assess performance. The Company’s CODM is the President and Chief Executive Officer. The CODM uses segment operating income or loss to allocate resources, which includes employee, financial, or capital resources, predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual and year-over-year variances on a monthly basis for segment operating income or loss when allocating capital and personnel resources to the segments. Segment performance is evaluated based on operating income of the respective business units before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), restructuring and other charges, including Portfolio Optimization Plan costs, and other costs (which are reported in Corporate & Other), interest expense, and income taxes.
 
The Company’s three reportable segments are the Flavors & Extracts and Color segments, which are both managed on a product line basis, and the Asia Pacific segment, which is managed on a geographic basis. The Company’s Flavors & Extracts segment produces flavor, extracts, and essential oils products that impart a desired taste, texture, aroma, or other characteristics to a broad range of consumer and other products. The Color segment produces natural and synthetic color systems for foods, beverages, pharmaceuticals, and nutraceuticals; colors, ingredients, and systems for personal care; and technical colors for industrial applications. The Asia Pacific segment is managed on a geographic basis and produces and distributes color, flavor, and essential oils products for the Asia Pacific countries. The Company’s corporate expenses, share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), restructuring and other charges, including Portfolio Optimization Plan costs as further described in Note 3, Portfolio Optimization Plan, and certain other costs are included in the “Corporate & Other” category.
 
9
 
Operating results by segment for the periods presented are as follows:
 
                     
(In thousands)  Flavors &
Extracts		   Color   Asia Pacific   
Corporate
& Other
   Consolidated 
Three months ended September 30, 2026:
                        
Total segment revenue
 $209,973   $210,343   $47,304   $              -    $467,620 
Intersegment revenue
  (6,136)    (5,400)    (243)     -     (11,779) 
Consolidated revenue from external customers
  203,837    204,943    47,061               -     455,841 
Cost of products sold
  146,313    118,945    25,635     -    290,893 
Selling and administrative expense
  27,005    39,944    9,062    16,488    92,499 
Operating income (loss)
  30,519    46,054    12,364    (16,488)    72,449 
Interest expense
                      8,345 
Earnings before income taxes
                     $64,104 
                          
Assets
  954,813    1,039,324    142,654    339,041    2,475,832 
Capital expenditures
  11,504    23,719    681    2,358    38,262 
Depreciation and amortization
  8,131    6,512    580    1,029    16,252 
                          
Three months ended September 30, 2025:
                        
Total segment revenue
 $202,970   $178,156   $42,082   $              -    $423,208 
Intersegment revenue
  (5,973)    (4,995)    (131)     -     (11,099) 
Consolidated revenue from external customers
  196,997    173,161    41,951               -     412,109 
Cost of products sold
  143,055    102,828    24,235    649    270,767 
Selling and administrative expense
  25,904    32,599    8,175    16,958    83,636 
Operating income (loss)
  28,038    37,734    9,541    (17,607)    57,706 
Interest expense
                      7,328 
Earnings before income taxes
                     $50,378 
                          
Assets
  884,996    886,367    129,655    308,523    2,209,541 
Capital expenditures
  10,648    7,196    584    1,325    19,753 
Depreciation and amortization
  7,736    6,249    604    967    15,556 
 
                     
(In thousands)   Flavors &
Extracts		    Color    Asia Pacific   
Corporate
& Other
    Consolidated 
Nine months ended September 30, 2026:
                        
Total segment revenue
 $624,977   $624,656   $140,148   $              -    $1,389,781 
Intersegment revenue
  (20,376)    (15,199)    (450)     -     (36,025) 
Consolidated revenue from external customers
  604,601    609,457    139,698               -     1,353,756 
Cost of products sold
  435,421    350,252    77,648         863,321 
Selling and administrative expense
  81,480    116,572    27,546    48,960    274,558 
Operating income (loss)
  87,700    142,633    34,504    (48,960)    215,877 
Interest expense
                      24,421 
Earnings before income taxes
                     $191,456 
                          
Assets
  954,813    1,039,324    142,654    339,041    2,475,832 
Capital expenditures
  35,717    62,732    1,674    5,652    105,775 
Depreciation and amortization
  23,802    19,036    1,743    3,099    47,680 
                          
Nine months ended September 30, 2025:
                        
Total segment revenue
 $599,902   $525,188   $126,727   $              -    $1,251,817 
Intersegment revenue
  (17,626)    (15,319)    (208)     -     (33,153) 
Consolidated revenue from external customers
  582,276    509,869    126,519               -     1,218,664 
Cost of products sold
  423,614    301,027    73,820    4,252    802,713 
Selling and administrative expense
  77,129    97,334    24,773    47,773    247,009 
Operating income (loss)
  81,533    111,508    27,926    (52,025)    168,942 
Interest expense
                      22,060 
Earnings before income taxes
                     $146,882 
                          
Assets
  884,996    886,367    129,655    308,523    2,209,541 
Capital expenditures
  37,655    15,677    1,188    3,268    57,788 
Depreciation and amortization
  23,052    18,247    1,722    2,869    45,890 
                     

 

10
 
Product Lines
 
(In thousands)
 
Flavors &
Extracts
   
Color
   
Asia Pacific
   
Consolidated
 
Three months ended September 30, 2026:
                   
Flavors, Extracts & Flavor Ingredients
$139,110  $               -   $               -   $139,110 
Agricultural Ingredients
  70,863     -      -     70,863 
Food & Pharmaceutical Colors
   -     164,457     -     164,457 
Personal Care
   -     45,886     -     45,886 
Asia Pacific
   -      -     47,304    47,304 
Intersegment Revenue
  (6,136)    (5,400)    (243)    (11,779) 
Total revenue from external customers
 $203,837   $204,943   $47,061   $455,841 
                     
Three months ended September 30, 2025:
                   
Flavors, Extracts & Flavor Ingredients
 $136,831   $               -    $               -    $136,831 
Agricultural Ingredients
  66,139     -      -     66,139 
Food & Pharmaceutical Colors
   -     133,548     -     133,548 
Personal Care
   -     44,608     -     44,608 
Asia Pacific
   -      -     42,082    42,082 
Intersegment Revenue
  (5,973)    (4,995)    (131)    (11,099) 
Total revenue from external customers
 $196,997   $173,161   $41,951   $412,109 
 
                 
(In thousands)
 
Flavors &
Extracts
   
Color
   
Asia Pacific
   
Consolidated
 
Nine months ended September 30, 2026:
                   
Flavors, Extracts & Flavor Ingredients
 $424,287   $               -    $               -    $424,287 
Agricultural Ingredients
  200,690                 -                  -     200,690 
Food & Pharmaceutical Colors
               -     483,478                 -     483,478 
Personal Care
               -     141,178                 -     141,178 
Asia Pacific
               -                  -     140,148    140,148 
Intersegment Revenue
  (20,376)    (15,199)    (450)    (36,025) 
Total revenue from external customers
 $604,601   $609,457   $139,698   $1,353,756 
                     
Nine months ended September 30, 2025:
                   
Flavors, Extracts & Flavor Ingredients
 $408,748   $               -    $               -    $408,748 
Agricultural Ingredients
  191,154                 -                  -     191,154 
Food & Pharmaceutical Colors
               -     394,525                 -     394,525 
Personal Care
               -     130,663                 -     130,663 
Asia Pacific
               -                  -     126,727    126,727 
Intersegment Revenue
  (17,626)    (15,319)    (208)    (33,153) 
Total revenue from external customers
 $582,276   $509,869   $126,519   $1,218,664 
 
Geographic Markets
 
(In thousands)
 
Flavors &
Extracts
   
Color
   
Asia Pacific
   
Consolidated
 
Three months ended September 30, 2026:
                   
North America
$165,877  $113,241  $2  $279,120 
Europe
  27,939    52,963     -     80,902 
Asia Pacific
  2,883    17,323    45,399    65,605 
Other
  7,138    21,416    1,660    30,214 
Total revenue from external customers
 $203,837   $204,943   $47,061   $455,841 
                     
Three months ended September 30, 2025:
                   
North America
 $154,755   $84,367   $41   $239,163 
Europe
  31,824    50,270    9    82,103 
Asia Pacific
  3,743    16,774    41,483    62,000 
Other
  6,675    21,750    418    28,843 
Total revenue from external customers
 $196,997   $173,161   $41,951   $412,109 
 
11
 
                 
(In thousands)
 
Flavors &
Extracts
   
Color
   
Asia Pacific
   
Consolidated
 
Nine months ended September 30, 2026:
                   
North America
 $485,071   $321,977   $94   $807,142 
Europe
  90,353    166,765    17    257,135 
Asia Pacific
  10,260    56,964    135,087    202,311 
Other
  18,917    63,751    4,500    87,168 
Total revenue from external customers
 $604,601   $609,457   $139,698   $1,353,756 
                     
Nine months ended September 30, 2025:
                   
North America
 $456,674   $247,438   $56   $704,168 
Europe
  93,265    148,679    47    241,991 
Asia Pacific
  12,987    50,448    123,325    186,760 
Other
  19,350    63,304    3,091    85,745 
Total revenue from external customers
 $582,276   $509,869   $126,519   $1,218,664 
 
9.
Retirement Plans
 
The Company’s components of annual benefit cost for the defined benefit plans for the periods presented are as follows:
 
                 
                     
   
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
  
(In thousands)
 
2026
  
2025
   
2026
   
2025
 
Service cost
 $307   $381   $933   $1,126 
Interest cost
  465    461    1,353    1,360 
Expected return on plan assets
  (278)    (280)    (834)    (821) 
Settlement income
  (276)     -     (276)     -  
Recognized actuarial gain
  (33)    (70)    (111)    (213) 
Total defined benefit expense
 $185   $492   $1,065   $1,452 
 
The Company’s non-service cost portion of defined benefit expense is recorded in Interest Expense on the Company’s Consolidated Statements of Earnings. The Company’s service cost portion of defined benefit expense is recorded in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings.
 
10.
Derivative Instruments and Hedging Activity
 
The Company may use forward exchange contracts and foreign currency denominated debt to manage its exposure to foreign exchange risk in order to reduce the effect of fluctuating foreign currencies on short-term foreign currency denominated intercompany transactions, non-functional currency raw material purchases, non-functional currency sales, and other known foreign currency exposures. These forward exchange contracts generally have maturities of less than 18 months. The Company’s primary hedging activities and their accounting treatment are summarized below.
 
Forward exchange contracts – Certain forward exchange contracts have been designated as cash flow hedges. The Company had $29.3 million and $49.9 million of forward exchange contracts designated as cash flow hedges outstanding as of September 30, 2026 and December 31, 2025, respectively. For the three months ended September 30, 2026 and 2025, the amounts reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period were not material. For each of the nine months ended September 30, 2026 and 2025, a gain of $1.1 million was reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period. In addition, the Company utilizes forward exchange contracts that are not designated as cash flow hedges. The results of these transactions were not material to the financial statements of the Company.
 
12
 
Net investment hedges – The Company has designated certain foreign currency denominated long-term borrowings as partial hedges of the Company’s foreign currency net asset positions. As of September 30, 2026 and December 31, 2025, the total value of the Company’s net investment hedges, which included Euro denominated long-term debt, was $298.6 million and $309.5 million, respectively. Changes in the fair value of this debt attributable to changes in the spot foreign exchange rate are recorded in foreign currency translation in Other Comprehensive Loss (OCL). For the three months ended September 30, 2026 and 2025, the impact of foreign exchange rates on these debt instruments decreased debt by $2.4 million and $2.1 million, respectively, which has been recorded as foreign currency translation in OCL. For the nine months ended September 30, 2026 and 2025, the impact of foreign exchange rates on these debt instruments decreased debt by $10.9 million and increased debt by $37.5 million, respectively, which has been recorded as foreign currency translation in OCL.
 
11.
Income Taxes
 
The effective income tax rates for the three months ended September 30, 2026 and 2025 were 24.6% and 26.6%, respectively. For the nine months ended September 30, 2026 and 2025, the effective income tax rates were 24.9% and 25.8%, respectively. The effective tax rates for the three and nine months ended September 30, 2026 and 2025 were impacted by the mix of foreign earnings and changes in estimates associated with the finalization of prior year foreign tax items. The effective tax rates for the three and nine months ended September 30, 2025 were further impacted by the limited tax deductibility of costs related to the Portfolio Optimization Plan.
 
12.
Accumulated Other Comprehensive Loss
 
The following table summarizes the changes in OCL during the three and nine month periods ended September 30, 2026 and 2025:
 
                 
(In thousands)  Cash Flow
Hedges (1)		   Pension
Items (1)		   Foreign
Currency
Items		   Total 
Balances at December 31, 2025
 $30   $(3,392)   $(166,891)   $(170,253) 
Other comprehensive income (loss) before reclassifications
  1,432     -     (9,585)    (8,153) 
Amounts reclassified from OCL
  (1,084)    (82)     -     (1,166) 
Balances at September 30, 2026
 $378   $(3,474)   $(176,476)   $(179,572) 
 
                 
(In thousands)
  Cash Flow
Hedges (1)		    Pension
Items (1)		    Foreign
Currency
Items 		    Total  
Balances at June 30, 2026
$952  $(3,450)  $(168,593)  $(171,091) 
Other comprehensive loss before reclassifications
  (137)     -     (7,883)    (8,020) 
Amounts reclassified from OCL
  (437)    (24)     -     (461) 
Balances at September 30, 2026
 $378   $(3,474)   $(176,476)   $(179,572) 
 
                 
(In thousands)
  Cash Flow
Hedges (1) 		    Pension
Items (1) 		    Foreign
Currency
Items 		    Total  
Balances at December 31, 2024
 $(310)   $(2,348)   $(224,181)   $(226,839) 
Other comprehensive income before reclassifications
  1,946     -     52,321    54,267 
Amounts reclassified from OCL
  (1,113)    (159)     -     (1,272) 
Balances at September 30, 2025
 $523   $(2,507)   $(171,860)   $(173,844) 
 
                 
(In thousands)
  Cash Flow
Hedges (1) 		    Pension
Items (1) 		    Foreign
Currency
Items 		    Total  
Balances at June 30, 2025
 $723   $(2,455)  $(171,747)   $(173,479) 
Other comprehensive income (loss) before reclassifications
  222     -     (113)    109 
Amounts reclassified from OCL
  (422)    (52)     -     (474) 
Balances at September 30, 2025
 $523   $(2,507)   $(171,860)   $(173,844) 
 
(1)
Cash Flow Hedges and Pension Items are net of tax.
 
13
 
13.
Commitments and Contingencies
 
The Company is subject to various claims and litigation arising in the normal course of business. The Company establishes reserves for claims and proceedings when it is probable that liabilities exist, and reasonable estimates of loss can be made. While it is not possible to predict the outcome of these matters, based on our assessment of the facts and circumstances now known, we do not believe that these matters, individually or in the aggregate, will have a material adverse effect on our financial position. However, actual outcomes may be different from those expected and could have a material effect on our results of operations or cash flows in a particular period.
 
14.
Subsequent Event
 
On October 29, 2026, the Company announced its quarterly dividend of $0.41 per share would be payable on December 1, 2026.
 
14
 
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
FORWARD-LOOKING STATEMENTS
 
This report contains forward-looking statements that reflect management’s current assumptions and estimates of future economic circumstances, industry conditions, Company performance, and financial results. Forward-looking statements include statements in the future tense, statements referring to any period after September 30, 2026, and statements including the terms “expect,” “believe,” “anticipate,” and other similar terms that express expectations as to future events or conditions. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that could cause actual events to differ materially from those expressed in the forward-looking statements. A variety of factors could cause the Company’s actual results and experience to differ materially from the anticipated results. These factors and assumptions include, among others, the Company’s ability to manage general business, economic, and capital market conditions, including actions taken by customers in response to such market conditions, and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies, disruptions and delays in the Company’s supply chain, and the conflicts between Russia and Ukraine and in the Middle East; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; the availability and cost of labor, logistics, and transportation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences, changing technologies, and changing regulations; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and Portfolio Optimization Plan; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; the Company’s ability to enhance its innovation efforts and drive cost efficiencies; currency exchange rate fluctuations; and the matters discussed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Except to the extent required by applicable law, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.
 
OVERVIEW
 
Revenue
Revenue was $455.8 million and $412.1 million for the three months ended September 30, 2026 and 2025, respectively. Revenue was $1.35 billion and $1.22 billion for the nine months ended September 30, 2026 and 2025, respectively. The increase in revenue for the three and nine months ended September 30, 2026 was primarily due to higher volumes and selling prices. Foreign exchange rates had an immaterial impact on consolidated revenue for the three months ended September 30, 2026. For the nine months ended September 30, 2026, the impact of foreign exchange rates increased consolidated revenue by approximately 2%.
 
Gross Margin
The Company’s gross margin was 36.2% and 34.3% for the three months ended September 30, 2026 and 2025, respectively. The Company’s gross margin was 36.2% and 34.1% for the nine months ended September 30, 2026 and 2025, respectively. For the three and nine months ended September 30, 2025, Portfolio Optimization Plan costs totaling $0.6 million and $4.3 million, respectively, decreased gross margin by 20 and 40 basis points, respectively. See Portfolio Optimization Plan below for further information. For the nine months ended September 30, 2026, the Company received $4.8 million of tariff refunds that improved gross margin by 40 basis points. The Company’s gross margins for the three and nine months ended September 30, 2026 were further impacted by the higher volumes and selling prices, partially offset by higher raw material costs.
 
Selling and Administrative Expenses
Selling and administrative expense as a percent of revenue was 20.3% for each of the three and nine months ended September 30, 2026 and 2025. For the three and nine months ended September 30, 2025, selling and administrative expenses were increased by Portfolio Optimization Plan costs totaling $2.7 and $5.3 million, respectively, which increased selling and administrative expenses as a percent of revenue by approximately 70 and 50 basis points, respectively. See Portfolio Optimization Plan below for further information. After the effects of the Portfolio Optimization Plan costs in 2025, the increase in selling and administrative expense as a percent of revenue for the three and nine months ended September 30, 2026 was primarily due to higher performance-based executive compensation costs incurred in 2026.
 
15
 
Operating Income
Operating income was $72.4 million and $57.7 million for the three months ended September 30, 2026 and 2025, respectively. Operating margins were 15.9% and 14.0% for the three months ended September 30, 2026 and 2025, respectively. Operating income was $215.9 million and $168.9 million for the nine months ended September 30, 2026 and 2025, respectively. Operating margins were 15.9% and 13.9% for the nine months ended September 30, 2026 and 2025, respectively. The tariff refunds increased operating margins by approximately 40 basis points for the nine months ended September 30, 2026. Portfolio Optimization Plan costs decreased operating margins by approximately 80 and 70 basis points for the three and nine months ended September 30, 2025, respectively. The Company’s operating margins for the three and nine months ended September 30, 2026 were further increased by the higher volumes and selling prices, partially offset by higher raw material costs and higher performance-based executive compensation costs incurred in 2026.
 
Interest Expense
Interest expense was $8.3 million and $7.3 million for the three months ended September 30, 2026 and 2025, respectively, and $24.4 million and $22.1 million for the nine months ended September 30, 2026 and 2025, respectively. The increase in expense for both the three and nine months ended September 30, 2026 was primarily due to an increase in the average outstanding debt balance.
 
Income Taxes
The effective income tax rates for the three months ended September 30, 2026 and 2025 were 24.6% and 26.6%, respectively. For the nine months ended September 30, 2026 and 2025, the effective income tax rates were 24.9% and 25.8%, respectively. The effective tax rates for the three and nine months ended September 30, 2026 and 2025 were impacted by the mix of foreign earnings and changes in estimates associated with the finalization of prior year foreign tax items. The effective tax rates for the three and nine months ended September 30, 2025 were further impacted by the limited tax deductibility of costs related to the Portfolio Optimization Plan.
 
Acquisition
On February 14, 2025, the Company acquired Biolie SAS, a natural color extraction business located in France. The Company paid $4.9 million in cash for this acquisition, which is net of $0.2 million in debt assumed. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $0.3 million, with the remaining $4.6 million allocated to goodwill. This business is part of the Color segment.
 
Portfolio Optimization Plan
During the fourth quarter of 2023, the Board of Directors of the Company approved a plan to undertake an effort to optimize certain production facilities and improve efficiencies within the Company (Portfolio Optimization Plan). As part of the Portfolio Optimization Plan, in the Flavors & Extracts segment, the Company evaluated the closure of its manufacturing facility in Felinfach, Wales, United Kingdom, the closure of its sales office in Granada, Spain, and the centralization and elimination of certain selling and administrative positions. In addition, in the Color segment, the Company evaluated the closure of a manufacturing facility in Delta, British Columbia, Canada, the closure of a sales office in Argentina, and centralizing and eliminating certain production positions and selling and administrative positions. The Company reports all costs associated with the Portfolio Optimization Plan in the Corporate & Other segment.
 
The Company’s Felinfach site was shut down in May 2025, and all production activities have been transferred to other locations. The Company began marketing the Felinfach site for sale in June 2025, at which point the held for sale criteria were met. These are the sole assets recorded in Fixed assets held for sale on the Company’s Consolidated Balance Sheet at December 31, 2025. The Company sold the land and building assets in February 2026 for approximately $2.0 million, resulting in a $0.4 million gain recognized in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings during the three months ended March 31, 2026. The Company has completed all actions contemplated under the Portfolio Optimization Plan.
 
For the three and nine months ended September 30, 2025, the Company incurred costs of $3.3 million and $9.5 million, respectively, related to the Portfolio Optimization Plan recorded in Corporate & Other, primarily for dual plant operating costs, professional services, non-cash inventory charges, decommissioning costs, and employee separation costs. The Company did not incur any costs related to the Portfolio Optimization Plan for the three or nine months ended September 30, 2026.
 
16
 
NON-GAAP FINANCIAL MEASURES
 
Within the following tables, the Company reports certain non-GAAP financial measures, including: (1) adjusted operating income, adjusted net earnings, and adjusted diluted earnings per share, which exclude restructuring and other costs, including the Portfolio Optimization Plan costs, (2) percentage changes in revenue, operating income, and diluted earnings per share on an adjusted local currency basis, which eliminate the effects that result from translating its international operations into U.S. dollars and restructuring and other costs, including the Portfolio Optimization Plan costs, and (3) adjusted EBITDA, which excludes restructuring and other costs, including the Portfolio Optimization Plan costs, and non-cash share-based compensation expense.
 
The Company has included each of these non-GAAP measures in order to provide additional information regarding its underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this report. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and the Company believes the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.
 
                          
   Three Months Ended September 30,    Nine Months Ended September 30,  
(In thousands, except per share amounts)  2026    2025    % Change    2026    2025    % Change  
Operating Income (GAAP)
 $ 72,449    $ 57,706     25.5 %  $ 215,877    $ 168,942     27.8 %
Portfolio Optimization Plan costs – Cost of products sold
   -      649            -      4,252        
Portfolio Optimization Plan costs – Selling and administrative expenses
   -      2,674            -      5,274        
Adjusted operating income
 $ 72,449    $ 61,029     18.7 %  $ 215,877    $ 178,468     21.0 %
                                         
Net Earnings (GAAP)
 $ 48,344    $ 36,956     30.8 %  $ 143,873    $ 109,005     32.0 %
Portfolio Optimization Plan costs, before tax
   -      3,323              -      9,526        
Tax impact of Portfolio Optimization Plan costs (1)
    -      649              -      (868 )       
Adjusted net earnings
 $ 48,344    $ 40,928     18.1 %  $ 143,873    $ 117,663     22.3 %
                                         
Diluted earnings per share (GAAP)
 $ 1.13    $ 0.87     29.9 %  $ 3.37    $ 2.56     31.6 %
Portfolio Optimization Plan costs, net of tax
   -      0.09              -      0.20        
Adjusted diluted earnings per share
 $ 1.13    $ 0.96     17.7 %  $ 3.37    $ 2.76     22.1 %
                                         
Operating Income (GAAP)
 $ 72,449    $ 57,706     25.5 %  $ 215,877      168,942     27.8 %
Depreciation and amortization
   16,252      15,556            47,680      45,890        
Share-based compensation expense
   4,382      3,945            13,762      10,584        
Portfolio Optimization Plan costs, before tax
   -      3,323            -       9,526        
Adjusted EBITDA
 $ 93,083    $ 80,530     15.6 %  $ 277,319    $ 234,942      18.0 %
 
(1) Tax impact adjustments were determined based on the nature of the underlying non-GAAP adjustments and their relevant jurisdictional tax rates.
 
Portfolio Optimization Plan costs are discussed under “Portfolio Optimization Plan” above and Note 3, Portfolio Optimization Plan, in the Notes to the Consolidated Financial Statements included in this report.
 
Note: Earnings per share calculations may not foot due to rounding differences.
 
17
 
The following table summarizes the percentage change for the results of the three and nine months ended September 30, 2026, compared to the results for the three and nine months ended September 30, 2025, in the respective financial measures.
 
                                 
                                         
   Three Months Ended September 30, 2026      Nine Months Ended September 30, 2026  
                                         
Revenue
 

Total  		   Foreign
Exchange
Rates  		  
 
Adjustments  (1)		   Adjusted
Local
Currency  		  

Total  		 Foreign
Exchange
Rates  		   

Adjustments  (1)		   Adjusted
Local
Currency  
Flavors & Extracts
  3.5%   0.3%    N/A     3.2%   4.2%   1.3%    N/A     2.9%
Color
  18.1%   1.1%    N/A     17.0%   18.9%   3.2%    N/A     15.7%
Asia Pacific
  12.4%   (2.4%)    N/A     14.8%   10.6%   0.0%    N/A     10.6%
Total Revenue
  10.6%   0.4%    N/A     10.2%   11.1%   2.0%    N/A     9.1%
                                         
Operating Income
                                       
Flavors & Extracts
  8.8%   0.0%   0.0%   8.8%   7.6%   0.9%   0.0%   6.7%
Color
  22.0%   0.9%   0.0%   21.1%   27.9%   3.8%   0.0%   24.1%
Asia Pacific
  29.6%   (2.8%)   0.0%   32.4%   23.6%   0.0%   0.0%   23.6%
Corporate & Other
  (6.4%)   0.0%   (21.8%)   15.4%   (5.9%)   0.0%   (21.1%)   15.2%
Total Operating Income
  25.5%   0.1%   6.8%   18.6%   27.8%   2.9%   6.7%   18.2%
Diluted Earnings per Share
  29.9%   0.0%   12.2%   17.7%   31.6%   3.1%   9.3%   19.2%
Adjusted EBITDA
  15.6%   0.2%    N/A     15.4%   18.0%   2.3%    N/A     15.7%
 
(1)
Adjustments consist of Portfolio Optimization Plan costs.
 
Note: Refer to table above for a reconciliation of these non-GAAP measures.
 
SEGMENT INFORMATION
 
The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. Segment performance is evaluated on operating income before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), restructuring and other costs, including the Portfolio Optimization Plan costs, and other costs (which are reported in Corporate & Other), interest expense, and income taxes.
 
The Company’s reportable segments consist of the Flavors & Extracts, Color, and Asia Pacific segments.
 
Flavors & Extracts
Flavors & Extracts segment revenue was $210.0 million and $203.0 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 4%. The increase was a result of higher revenue in Agricultural Ingredients and Flavors, Extracts & Flavor Ingredients. The higher revenue in Agricultural Ingredients was due to higher volumes. The higher revenue in Flavors, Extracts & Flavor Ingredients was primarily due to higher selling prices, partially offset by lower volumes. Foreign exchange rates had an immaterial impact on segment revenue for the three months ended September 30, 2026.
 
Flavors & Extracts segment revenue was $625.0 million and $599.9 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 4%. The increase was a result of higher revenue in Flavors, Extracts & Flavor Ingredients and Agricultural Ingredients. The higher revenue in Flavors, Extracts & Flavor Ingredients was primarily due to higher selling prices and the favorable impact of foreign exchange rates that increased segment revenue by approximately 1%. The higher revenue in Agricultural Ingredients was due to higher volumes and selling prices.
 
Flavors & Extracts segment operating income was $30.5 million and $28.0 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 9%. The higher segment operating income was primarily a result of higher operating income in Flavors, Extracts & Flavor Ingredients, primarily due to higher selling prices and favorable product mix, partially offset by higher manufacturing and other costs. Segment operating income as a percent of revenue was 14.5% in the current quarter compared to 13.8% in the prior year’s comparable quarter. Foreign exchange rates had an immaterial impact on segment operating income for the three months ended September 30, 2026.
 
Flavors & Extracts segment operating income was $87.7 million and $81.5 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 8%. The higher segment operating income was a result of higher operating income in Flavors, Extracts & Flavor Ingredients and Agricultural Ingredients. The higher segment operating income for Flavors, Extracts & Flavor Ingredients was primarily due to higher selling prices, favorable product mix, and higher volumes, partially offset by higher manufacturing and other costs. The higher segment operating income for Agricultural Ingredients was due to higher selling prices, favorable product mix, and higher volumes, partially offset by higher raw material costs and manufacturing and other costs. Segment operating income as a percent of revenue was 14.0% in the current nine month period compared to 13.6% in the prior year’s comparable nine month period. Foreign exchange rates increased segment operating income by approximately 1% for the nine months ended September 30, 2026.
 
18
 
Color
Segment revenue for the Color segment was $210.3 million and $178.2 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 18%. The increase was primarily a result of higher revenue in Food & Pharmaceutical Colors, primarily due to higher volumes, including higher volumes associated with natural colors conversion activity, and the favorable impact of foreign exchange rates that increased segment revenue by approximately 1%.
 
Segment revenue for the Color segment was $624.7 million and $525.2 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 19%. The increase was a result of higher revenue in Food & Pharmaceutical Colors and Personal Care. The higher revenue in Food & Pharmaceutical Colors was due to higher volumes, including higher volumes associated with natural colors conversion activity, the favorable impact of foreign exchange rates, and higher selling prices. The higher revenue in Personal Care was due to the favorable impact of foreign exchange rates, higher selling prices, and higher volumes. Foreign exchange rates increased segment revenue by approximately 3% for the nine months ended September 30, 2026.
 
Segment operating income for the Color segment was $46.1 million and $37.7 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 22%. The higher segment operating income was a result of higher operating income in Food & Pharmaceutical Colors and Personal Care. The higher operating income in Food & Pharmaceutical Colors was primarily due to higher volumes, partially offset by higher raw material and manufacturing and other costs. The higher operating income in Personal Care was primarily due to higher selling prices. Foreign exchange rates increased segment operating income by approximately 1% for the three months ended September 30, 2026. Segment operating income as a percent of revenue was 21.9% in the current quarter and 21.2% in the prior year’s comparable quarter.
 
Segment operating income for the Color segment was $142.6 million and $111.5 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 28%. The higher segment operating income was a result of higher operating income in Food & Pharmaceutical Colors and Personal Care. The higher operating income in Food & Pharmaceutical Colors was due to higher volumes and selling prices, the favorable impact of tariff refunds received, and the favorable impact of foreign exchange rates, partially offset by higher raw material and manufacturing and other costs. The higher operating income in Personal Care was primarily due to higher selling prices and volumes, the favorable impact of tariff refunds received, and the favorable impact of foreign exchange rates, partially offset by higher manufacturing and other costs. Foreign exchange rates increased segment operating income by approximately 4% for the nine months ended September 30, 2026. Segment operating income as a percent of revenue was 22.8% in the current nine month period and 21.2% in the prior year’s comparable period.
 
Asia Pacific
Segment revenue for the Asia Pacific segment was $47.3 million and $42.1 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 12%. The increase was a result of higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates that decreased segment revenue by approximately 2%.
 
Segment revenue for the Asia Pacific segment was $140.1 million and $126.7 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 11%. The increase was a result of higher volumes and selling prices. Foreign exchange rates had an immaterial impact on segment revenue for the nine months ended September 30, 2026.
 
Segment operating income for the Asia Pacific segment was $12.4 million and $9.5 million for the three months ended September 30, 2026 and 2025, respectively, an increase of approximately 30%. The increase was primarily due to higher volumes and selling prices, partially offset by higher manufacturing and other costs and the unfavorable impact of foreign exchange rates that decreased segment operating income by approximately 3%. Segment operating income as a percent of revenue was 26.1% in the current quarter and 22.7% in the prior year’s comparable quarter.
 
Segment operating income for the Asia Pacific segment was $34.5 million and $27.9 million for the nine months ended September 30, 2026 and 2025, respectively, an increase of approximately 24%. The increase was primarily due to higher volumes and selling prices, partially offset by higher manufacturing and other costs. Segment operating income as a percent of revenue was 24.6% in the current nine month period and 22.0% in the prior year’s comparable period. Foreign exchange rates had an immaterial impact on segment operating income for the nine months ended September 30, 2026.
 
19
 
Corporate & Other
The Corporate & Other operating expense was $16.5 million and $17.6 million for the three months ended September 30, 2026 and 2025, respectively. The lower operating expense was primarily due to Portfolio Optimization Plan costs totaling $3.3 million in the three months ended September 30, 2025, partially offset by higher performance-based executive compensation costs incurred in 2026. See the Portfolio Optimization Plan section above for further information.
 
The Corporate & Other operating expense was $49.0 million and $52.0 million for the nine months ended September 30, 2026 and 2025, respectively. The lower operating expense was primarily due to Portfolio Optimization Plan costs totaling $9.5 million in the nine months ended September 30, 2025, partially offset by higher performance-based executive compensation costs incurred in 2026. See the Portfolio Optimization Plan section above for further information.
 
LIQUIDITY AND FINANCIAL CONDITION
 
Financial Condition
The Company’s financial position remains strong. The Company is in compliance with its loan covenants calculated in accordance with applicable agreements as of September 30, 2026. The Company expects to increase its existing indebtedness in the short-term to further support the increased cash requirements for operations and capital expenditures associated with the natural colors conversion activity. In the long-term, the Company anticipates that its cash flow from operations and debt capacity can be used to meet anticipated future cash requirements for operations, capital expenditures, and dividend payments, as well as potential acquisitions and stock repurchases. The Company’s contractual obligations consist primarily of operational commitments, which we expect to continue to be able to satisfy through cash generated from operations, and debt. The Company has various series of notes outstanding that mature from 2026 through 2030. The Company believes that it has the ability to refinance or repay these obligations through a combination of cash flow from operations, issuance of additional notes, and sufficient borrowing capacity under the Company’s revolving credit facility, which matures in 2030.
 
As a result of our ability to manage the impact of inflation through pricing and other actions, the impact of inflation was not material to the Company’s financial position and its results of operations for the three months ended September 30, 2026. The Company has experienced increased costs for certain inputs, such as raw materials, energy, shipping and logistics, packaging, and labor-related costs. We continue to expect to manage these impacts in the near term, but persistent, accelerated, or expanded inflationary conditions, including any heightened inflationary pressures resulting from the conflict between the United States and Iran and its aftermath, could exacerbate these challenges and impact our profitability.
 
The Company continues to monitor developments with respect to tariffs and other trade policy matters closely, including impacts from the U.S. Supreme Court decision that struck down tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) and other litigation, as well as the implementation of additional tariffs. As of September 30, 2026, we have received approximately $5 million of IEEPA tariff refunds from the U.S. Customs and Border Protection, which included applicable interest. We do not anticipate receiving any material amounts of tariff refunds in the future. The tariffs imposed by the United States, and retaliatory tariffs imposed by other countries on United States exports, have led to significant volatility and uncertainty in global markets. As a result of these ongoing tariff-related actions, the Company anticipates incurring incremental tariff costs on certain raw materials to produce our products and certain finished goods shipped to customers. However, the Company expects to manage the impact of the increased tariff costs through pricing actions. To the extent the Company is unable to offset the increased tariff costs, or the tariffs negatively impact demand, or other trade barriers are implemented, the Company’s revenue and profitability would be adversely impacted. If additional tariffs are adopted, the Company would incur additional tariff costs that could be material.
 
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The OBBBA includes a broad range of tax reform provisions, such as the extension of certain expiring provisions, modifications to the international tax framework, and the continuation of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions implemented through 2027. These provisions did not have a material impact on our effective tax rate for the three or nine months ended September 30, 2026. We will continue to assess the OBBBA tax provisions and their impacts on our consolidated financial statements.
 
Cash Flows from Operating Activities
Net cash provided by operating activities was $75.3 million and $83.3 million for the nine months ended September 30, 2026 and 2025, respectively. The decrease in net cash provided by operating activities was primarily due to an increase in cash used by inventory during 2026 compared to 2025 and a decrease in cash provided by accounts receivable, partially offset by an increase in cash provided by accounts payable and other accrued expenses.
 
20
 
Cash Flows from Investing Activities
Net cash used in investing activities was $104.3 million and $61.0 million during the nine months ended September 30, 2026 and 2025, respectively. Capital expenditures were $105.8 million and $57.8 million during the nine months ended September 30, 2026 and 2025, respectively. In 2026, the Company received $2.0 million for the sale of the Felinfach land and building assets. In 2025, the Company paid $4.9 million for the acquisition of Biolie SAS.
 
Cash Flows from Financing Activities
Net cash provided by financing activities was $35.0 million and net cash used in financing activities was $13.9 million for the nine months ended September 30, 2026 and 2025, respectively. Net debt increased by $91.8 million and $41.0 million for the nine months ended September 30, 2026 and 2025, respectively. The cash proceeds from the increase in net debt in the current period were primarily used to support capital expenditure investments during the nine months ended September 30, 2026. For purposes of the cash flow statement, net changes in debt exclude the impact of foreign exchange rates. Dividends of $52.3 million and $52.2 million were paid during the nine months ended September 30, 2026 and 2025, respectively. Total dividends of $1.23 per share were paid for both the nine months ended September 30, 2026 and 2025.
 
CRITICAL ACCOUNTING POLICIES
 
There have been no material changes in the Company’s critical accounting policies during the quarter ended September 30, 2026. For additional information about the Company’s critical accounting policies, refer to “Critical Accounting Policies” under Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
 
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
There have been no material changes in the Company’s exposure to market risk during the quarter ended September 30, 2026. For additional information about market risk, refer to Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
 
ITEM 4.
CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures: The Company carried out an evaluation, under the supervision and with the participation of management, including the Company’s Chairman, President, and Chief Executive Officer and its Vice President and Chief Financial Officer, of the effectiveness, as of the end of the period covered by this report, of the design and operation of the disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the Company’s Chairman, President, and Chief Executive Officer and its Vice President and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.
 
Changes in Internal Control over Financial Reporting: During the quarter ended September 30, 2026, the Company upgraded an enterprise resource planning software application used in business units within the Color segment. The Company followed an implementation process that required significant pre-implementation planning, design, and testing. There have been no other changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
PART II.
OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS
 
See Part I, Item 1, Note 13, Commitments and Contingencies, of this report for information regarding legal proceedings in which the Company is involved.
 
ITEM 1A.
RISK FACTORS
 
There were no material changes to the risk factors previously disclosed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
 
21
 
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
On October 19, 2017, the Board of Directors authorized the repurchase of up to three million shares (2017 Authorization). As of September 30, 2026, 1,267,019 shares had been repurchased under the 2017 Authorization. There is no expiration date for the 2017 Authorization. The 2017 Authorization may be modified, suspended, or discontinued by the Board of Directors at any time. As of September 30, 2026, the maximum number of shares that may be purchased under publicly announced plans is 1,732,981. No shares were purchased by the Company during the three or nine months ended September 30, 2026.
 
ITEM 5.
OTHER INFORMATION
 
Rule 10b5-1 Trading Arrangements
During the three months ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
 
ITEM 6.
EXHIBITS
 
The exhibits listed in the following Exhibit Index are filed as part of this Quarterly Report on Form 10-Q.
 
22
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2026
 
     
Exhibit
Description
 
Incorporated by Reference From
Filed Herewith
        
10.1
Omnibus Amendment No. 1 to Receivables Purchase Agreement and Performance Undertaking, dated as of August 31, 2026, among Sensient Receivables LLC, Sensient Technologies Corporation, Wells Fargo Bank, National Association, PNC Bank, National Association, and PNC Capital Markets LLC
  Exhibit 10.1 to Current Report on Form 8-K filed September 2, 2026 (Commission File No. 1-7626)  
        
10.2
First Amendment to Fourth Amended and Restated Credit Agreement, dated as of October 28, 2026
    X
        
31
Certifications of the Company’s Chairman, President & Chief Executive Officer and Vice President & Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act
   X
        
32
Certifications of the Company’s Chairman, President & Chief Executive Officer and Vice President & Chief Financial Officer pursuant to 18 United States Code § 1350
   X
        
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
   X
        
101.SCH
Inline XBRL Taxonomy Extension Schema Document
   X
        
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
   X
        
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
   X
        
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
   X
        
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
   X
        
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
   X
 
23
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
         
    SENSIENT TECHNOLOGIES CORPORATION
         
Date: October 30, 2026 By: /s/ John J. Manning  
      John J. Manning, Senior Vice President, General Counsel & Secretary  
         
Date: October 30, 2026 By: /s/ Tobin Tornehl  
      Tobin Tornehl, Vice President & Chief Financial Officer  
 
 
 
24
Sensient Technologies Corp WI 2030-03-01 0000310142 false Q3 --12-31 0000310142 2026-01-01 2026-09-30 0000310142 2026-10-22 0000310142 2026-07-01 2026-09-30 0000310142 2025-07-01 2025-09-30 0000310142 2025-01-01 2025-09-30 0000310142 2026-09-30 0000310142 2025-12-31 0000310142 2024-12-31 0000310142 2025-09-30 0000310142 us-gaap:CommonStockMember 2026-06-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000310142 us-gaap:RetainedEarningsMember 2026-06-30 0000310142 us-gaap:TreasuryStockCommonMember 2026-06-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0000310142 2026-06-30 0000310142 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0000310142 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2026-07-01 2026-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0000310142 us-gaap:CommonStockMember 2026-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0000310142 us-gaap:RetainedEarningsMember 2026-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2026-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0000310142 us-gaap:CommonStockMember 2025-06-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000310142 us-gaap:RetainedEarningsMember 2025-06-30 0000310142 us-gaap:TreasuryStockCommonMember 2025-06-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000310142 2025-06-30 0000310142 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000310142 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0000310142 us-gaap:CommonStockMember 2025-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000310142 us-gaap:RetainedEarningsMember 2025-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2025-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0000310142 us-gaap:CommonStockMember 2025-12-31 0000310142 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000310142 us-gaap:RetainedEarningsMember 2025-12-31 0000310142 us-gaap:TreasuryStockCommonMember 2025-12-31 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0000310142 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0000310142 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-09-30 0000310142 us-gaap:CommonStockMember 2024-12-31 0000310142 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000310142 us-gaap:RetainedEarningsMember 2024-12-31 0000310142 us-gaap:TreasuryStockCommonMember 2024-12-31 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000310142 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0000310142 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0000310142 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0000310142 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-09-30 0000310142 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0000310142 sxt:BiolieSASMember 2025-02-14 2025-02-14 0000310142 sxt:BiolieSASMember 2025-02-14 0000310142 2026-02-28 2026-02-28 0000310142 us-gaap:SellingGeneralAndAdministrativeExpense 2026-02-28 2026-02-28 0000310142 sxt:FlavorsAndExtractsMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-07-01 2025-09-30 0000310142 sxt:ColorMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-07-01 2025-09-30 0000310142 us-gaap:SellingGeneralAndAdministrativeExpense 2025-07-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember us-gaap:CostOfGoodsAndServicesSold 2025-07-01 2025-09-30 0000310142 sxt:ColorMember us-gaap:CostOfGoodsAndServicesSold 2025-07-01 2025-09-30 0000310142 us-gaap:CostOfGoodsAndServicesSold 2025-07-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 sxt:ColorMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-01-01 2025-09-30 0000310142 sxt:ColorMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-01-01 2025-09-30 0000310142 us-gaap:CorporateAndOtherMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-01-01 2025-09-30 0000310142 us-gaap:SellingGeneralAndAdministrativeExpense 2025-01-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember us-gaap:CostOfGoodsAndServicesSold 2025-01-01 2025-09-30 0000310142 sxt:ColorMember us-gaap:CostOfGoodsAndServicesSold 2025-01-01 2025-09-30 0000310142 us-gaap:CorporateAndOtherMember us-gaap:CostOfGoodsAndServicesSold 2025-01-01 2025-09-30 0000310142 us-gaap:CostOfGoodsAndServicesSold 2025-01-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 sxt:ColorMember 2025-01-01 2025-09-30 0000310142 us-gaap:CorporateAndOtherMember 2025-01-01 2025-09-30 0000310142 currency:EUR sxt:SeniorNotesDueMarch2030Member sxt:MasterNoteAgreementMember 2026-03-27 0000310142 sxt:SeniorNotesDueMarch2030Member 2026-03-27 2026-03-27 0000310142 sxt:SeniorNotesDueMarch2030Member 2026-03-27 0000310142 srt:MaximumMember sxt:TermLoanMember 2026-06-18 0000310142 srt:MaximumMember sxt:TermLoanMember 2026-06-18 2026-06-18 0000310142 sxt:TermLoanMember 2026-06-18 2026-06-18 0000310142 sxt:TermLoanMember 2026-09-30 0000310142 sxt:ReceivablesPurchaseAgreementMember 2026-08-30 2026-08-30 0000310142 sxt:ReceivablesPurchaseAgreementMember 2026-08-31 2026-08-31 0000310142 us-gaap:FairValueInputsLevel2Member 2026-09-30 0000310142 us-gaap:FairValueInputsLevel2Member 2025-12-31 0000310142 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2026-09-30 0000310142 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-12-31 0000310142 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-09-30 0000310142 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0000310142 us-gaap:OperatingSegmentsMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2026-07-01 2026-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2026-07-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember 2026-07-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember us-gaap:CorporateAndOtherMember 2026-07-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 sxt:ColorMember 2026-07-01 2026-09-30 0000310142 sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsAndExtractsMember 2026-09-30 0000310142 sxt:ColorMember 2026-09-30 0000310142 sxt:AsiaPacificSegmentMember 2026-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2025-07-01 2025-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2025-07-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember us-gaap:CorporateAndOtherMember 2025-07-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember 2025-07-01 2025-09-30 0000310142 sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsAndExtractsMember 2025-09-30 0000310142 sxt:ColorMember 2025-09-30 0000310142 sxt:AsiaPacificSegmentMember 2025-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember 2026-01-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-09-30 0000310142 us-gaap:IntersegmentEliminationMember 2026-01-01 2026-09-30 0000310142 sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 sxt:ColorMember 2026-01-01 2026-09-30 0000310142 sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-09-30 0000310142 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-09-30 0000310142 us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-09-30 0000310142 us-gaap:IntersegmentEliminationMember 2025-01-01 2025-09-30 0000310142 sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember 2026-07-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember 2026-07-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember 2026-07-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 sxt:PersonalCareMember 2026-07-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember 2025-07-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember 2025-07-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember 2025-07-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 sxt:PersonalCareMember 2025-07-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember 2026-01-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 sxt:AgriculturalIngredientsMember 2026-01-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember 2026-01-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 sxt:PersonalCareMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 sxt:PersonalCareMember 2026-01-01 2026-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 sxt:FlavorsExtractsFlavorIngredientsMember 2025-01-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 sxt:AgriculturalIngredientsMember 2025-01-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 sxt:FoodPharmaceuticalColorsMember 2025-01-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 sxt:PersonalCareMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 sxt:PersonalCareMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 srt:NorthAmericaMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 srt:EuropeMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 srt:AsiaPacificMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:FlavorsAndExtractsMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:ColorMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:AsiaPacificSegmentMember 2026-07-01 2026-09-30 0000310142 us-gaap:AllOtherSegmentsMember 2026-07-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 srt:NorthAmericaMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 srt:EuropeMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 srt:AsiaPacificMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:FlavorsAndExtractsMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:ColorMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:AsiaPacificSegmentMember 2025-07-01 2025-09-30 0000310142 us-gaap:AllOtherSegmentsMember 2025-07-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 srt:NorthAmericaMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 srt:EuropeMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 srt:AsiaPacificMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:FlavorsAndExtractsMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:ColorMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:AsiaPacificSegmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:AllOtherSegmentsMember 2026-01-01 2026-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:NorthAmericaMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 srt:NorthAmericaMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:EuropeMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 srt:EuropeMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember srt:AsiaPacificMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 srt:AsiaPacificMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:FlavorsAndExtractsMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:ColorMember 2025-01-01 2025-09-30 0000310142 srt:ReportableGeographicalComponentsMember us-gaap:AllOtherSegmentsMember sxt:AsiaPacificSegmentMember 2025-01-01 2025-09-30 0000310142 us-gaap:AllOtherSegmentsMember 2025-01-01 2025-09-30 0000310142 us-gaap:PensionPlansDefinedBenefitMember 2026-07-01 2026-09-30 0000310142 us-gaap:PensionPlansDefinedBenefitMember 2025-07-01 2025-09-30 0000310142 us-gaap:PensionPlansDefinedBenefitMember 2026-01-01 2026-09-30 0000310142 us-gaap:PensionPlansDefinedBenefitMember 2025-01-01 2025-09-30 0000310142 srt:MaximumMember 2026-01-01 2026-09-30 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2026-09-30 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-12-31 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-07-01 2025-09-30 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2026-07-01 2026-09-30 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2026-01-01 2026-09-30 0000310142 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-01-01 2025-09-30 0000310142 us-gaap:DebtMember 2026-09-30 0000310142 us-gaap:DebtMember 2025-12-31 0000310142 us-gaap:DebtMember 2026-07-01 2026-09-30 0000310142 us-gaap:DebtMember 2025-07-01 2025-09-30 0000310142 us-gaap:DebtMember 2026-01-01 2026-09-30 0000310142 us-gaap:DebtMember 2025-01-01 2025-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-12-31 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-12-31 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2025-12-31 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-01-01 2026-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2026-01-01 2026-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2026-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-06-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-06-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2026-06-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-07-01 2026-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-07-01 2026-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2026-07-01 2026-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-31 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-31 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-01-01 2025-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2025-01-01 2025-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2025-09-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-06-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-06-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2025-06-30 0000310142 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-07-01 2025-09-30 0000310142 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-07-01 2025-09-30 0000310142 us-gaap:AccumulatedTranslationAdjustmentMember 2025-07-01 2025-09-30 0000310142 sxt:O2026Q3DividendsMember us-gaap:SubsequentEventMember 2026-10-29 2026-10-29 0000310142 sxt:O2026Q3DividendsMember us-gaap:SubsequentEventMember 2026-10-29 xbrli:shares iso4217:USD iso4217:USD xbrli:shares sxt:Positions sxt:Segment iso4217:EUR xbrli:pure sxt:Advance
Exhibit 10.2
 
FIRST AMENDMENT TO CREDIT AGREEMENT
 
This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is dated as of October 28, 2026 and is by and among SENSIENT TECHNOLOGIES CORPORATION, a Wisconsin corporation (the “Company”), the financial institutions signatory hereto as Lenders, and PNC BANK, NATIONAL ASSOCIATION, a national banking association, as the Administrative Agent, the Issuing Bank, and the Swing Line Lender.
 
Unless otherwise indicated, all capitalized terms used herein and not otherwise defined shall have the respective meanings provided such terms in the Credit Agreement referred to below.
 
W I T N E S S E T H :
 
WHEREAS, the Company, the other Borrowers party thereto, the Lenders and the Administrative Agent are parties to a certain Fourth Amended and Restated Credit Agreement, dated as of June 13, 2025 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”);
 
WHEREAS, the Company, the Administrative Agent and the Lenders wish to amend the Credit Agreement on the terms and conditions set forth herein.
 
NOW, THEREFORE, in consideration of the premises set forth above, the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
 
1.
Amendments to Credit Agreement. Upon the First Amendment Effective Date (as defined below), the Credit Agreement is hereby amended as follows:
 
(a)
The following defined terms are hereby added to Section 1.1 of the Credit Agreement in appropriate alphabetical order:
 
“TIBOR” has the meaning specified in the definition of Eurocurrency Rate.
 
“TONAR” means a rate equal to the Tokyo Overnight Average Rate as administered by the TONAR Administrator.
 
“TONAR Administrator” means the Bank of Japan (or any successor administrator of the Tokyo Overnight Average Rate selected by the Administrative Agent in its reasonable discretion).
 
“TONAR Administrator’s Website” means the Bank of Japan’s website, at http://www.boj.or.jp, or any successor source for the Tokyo Overnight Average Rate identified as such by the TONAR Administrator from time to time.
 
“Yen” or “¥” mean the lawful currency of Japan.
 
(b)
The definition of “Alternative Currency” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
1
 
“Alternative Currency” means Euros, English pounds, Yen or any other currency (other than Dollars) which is (a) readily available, freely transferable and convertible into Dollars in the international interbank market, available to the Lenders in such market and as to which a Dollar Equivalent may be readily calculated, (b) requested by any Borrower and (c) acceptable to all of the Lenders (or, for purposes of any Alternative Currency Letter of Credit, any such other currency that is acceptable to the Issuing Bank), in each case as long as there is a published Daily Simple RFR or Eurocurrency Rate, as applicable, or a Benchmark Replacement effected pursuant to Section 2.18(k) with respect thereto.
 
(c)
The definition of “Benchmark” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Benchmark” means, initially, with respect to Obligations, interest, fees, commissions, or other amounts denominated in, or calculated with respect to, (a) Dollars, SOFR and Term SOFR Reference Rate, (b) Euros, Sterling or Yen, the Daily Simple RFR applicable for such Currency, and (c) Euros or Yen, the Eurocurrency Rate applicable for such Currency; provided that if a Benchmark Transition Event has occurred with respect to the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 2.18(k)(i).
 
(d)
The definition of “Benchmark Replacement” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Benchmark Replacement” with respect to any Benchmark Transition Event, the first applicable alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date:
 
(1) where the Benchmark is Term SOFR, Daily Simple SOFR;
 
(2) where the Benchmark is EURIBOR, €STR;
 
(3) where the Benchmark is TIBOR, TONAR; and
 
(4) the sum of (A) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower, giving due consideration to (x) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (y) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for syndicated credit facilities denominated in the applicable Currency at such time and (B) the related Benchmark Replacement Adjustment;
 
provided, that if the Benchmark Replacement as determined pursuant to the foregoing would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents; and provided further, that any Benchmark Replacement shall be administratively feasible as determined by the Administrative Agent in its sole discretion.
 
2
 
(e)
The definition of “Daily RFR Administrator” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Daily RFR Administrator” means the SONIA Administrator, the €STR Administrator or the TONAR Administrator, as applicable.
 
(f)
The definition of “Daily RFR Business Day” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Daily RFR Business Day” means as applicable, for any Obligations, interest, fees, commissions or other amounts denominated in, or calculated with respect to (i) Euro, a TARGET Day, (ii) Sterling, a day on which banks are open for general business in London, and (iii) Yen, a day on which banks are open for general business in Japan.
 
(g)
The definition of “Daily Simple RFR” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Daily Simple RFR” means, for any day (a “Daily RFR Day”), a rate per annum determined by the Administrative Agent (rounded upwards, at the Administrative Agent’s discretion, to the nearest 1/100 of 1%) equal to, for any Obligations, interest, fees, commissions or other amounts denominated in, or calculated with respect to:
 
(a) Sterling, SONIA for the day (such day, adjusted as applicable as set forth herein, the “SONIA Lookback Day”) that is two (2) Daily RFR Business Days prior to (A) if such Daily RFR Day is a Daily RFR Business Day, such Daily RFR Day or (B) if such Daily RFR Day is not a Daily RFR Business Day, the Daily RFR Business Day immediately preceding such Daily RFR Day, in each case, as such SONIA is published by the SONIA Administrator on the SONIA Administrator’s Website;
 
(b) Euro, €STR for the day (such day, adjusted as applicable as set forth herein, the “€STR Lookback Day”) that is two (2) Daily RFR Business Days prior to (A) if such Daily RFR Day is a Daily RFR Business Day, such Daily RFR Day or (B) if such Daily RFR Day is not a Daily RFR Business Day, the Daily RFR Business Day immediately preceding such Daily RFR Day, in each case, as such €STR is published by the €STR Administrator on the €STR Administrator’s Website; and
 
(c) Yen, TONAR for the day (such day, adjusted as applicable as set forth herein, the “TONAR Lookback Day”) that is two (2) Daily RFR Business Days prior to (A) if such Daily RFR Day is a Daily RFR Business Day, such Daily RFR Day or (B) if such Daily RFR Day is not a Daily RFR Business Day, the Daily RFR Business Day immediately preceding such Daily RFR Day, in each case, as such TONAR is published by the TONAR Administrator on the TONAR Administrator’s Website;
 
3
 
provided, that if by 5:00 pm (local time for the applicable Daily Simple RFR) on the second (2nd) Daily RFR Business Day immediately following any Daily Simple RFR Lookback Day, the RFR in respect of such Daily Simple RFR Lookback Day has not been published on the applicable Daily RFR Administrator’s website and a Benchmark Replacement Date with respect to the applicable Daily Simple RFR has not occurred, then the RFR for such Daily Simple RFR Lookback Day will be the RFR as published in respect of the first preceding Daily RFR Business Day for which such RFR was published on the Daily RFR Administrator’s website; provided further that any RFR determined pursuant to this sentence shall be utilized for purposes of calculation of Daily Simple RFR for no more than three (3) consecutive Daily RFR Days; provided further that if the Daily Simple RFR as determined above would be less than the Floor, such rate shall be deemed to be the Floor for purposes of this Agreement.
 
The Daily Simple RFR for each outstanding Daily RFR Funding shall be adjusted automatically as of the effective date of any change in the applicable RFR without notice to the Borrower. Determination by Administrative Agent of the Daily Simple RFR shall be deemed conclusive absent manifest error.
 
(h)
The definition of “Daily Simple RFR Lookback Days” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Daily Simple RFR Lookback Days” means, collectively, the SONIA Lookback Day, €STR Lookback Day and TONAR Lookback Day, as applicable, and each individually is a Daily Simple RFR Lookback Day.
 
(i)
The definition of “Eurocurrency Banking Day” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Eurocurrency Banking Day” means, for Obligations, interest, fees, commissions or other amounts denominated in, or calculated with respect to (i) Euros, a TARGET Day, and (ii) Yen, any day on which banks are open for business in Japan.
 
(j)
The definition of “Eurocurrency Rate” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Eurocurrency Rate” means, for any Eurocurrency Rate Funding for any Interest Period, a rate per annum determined by the Administrative Agent (rounded upwards, at the Administrative Agent’s discretion, to the nearest 1/100 of 1%) equal to, for any Obligations, interest, fees, commissions, or other amounts denominated in, or calculated with respect to:
 
(a)
Euros, the Euro Interbank Offered Rate (“EURIBOR”) as administered by the European Money Markets Institute (or any other Person that takes over the administration of such rate) for a period equal in length to such Interest Period, as displayed on the applicable Bloomberg page (or on any successor or substitute page or service providing such quotations as determined by the Administrative Agent from time to time) at approximately 11:00 a.m. (Brussels time) two (2) Eurocurrency Banking Days prior to the commencement of such Interest Period; provided, that if by such time the EURIBOR in respect of such day has not been so published, or if such day is not a Business Day, then the EURIBOR for such day will be the EURIBOR as published in respect of the first preceding Business Day for which such EURIBOR rate was published thereon; provided further that any EURIBOR so determined based on the first preceding Business Day shall be utilized for purposes of calculation of the Eurocurrency Rate for no more than three (3) consecutive Business Days (any such day, collectively, the “EURIBOR Lookback Day”); and
 
4
 
(b)
Yen, the Tokyo Interbank Offered Rate (“TIBOR”) as administered by the Ippan Shadan Hojin JBA TIBOR Administration (or any other Person that takes over the administration of such rate) for a period equal in length to such Interest Period, as displayed on the applicable Bloomberg page (or on any successor or substitute page or service providing such quotations as determined by the Administrative Agent from time to time) at approximately 11:00 a.m. (Tokyo time) two (2) Business Days prior to the commencement of such Interest Period; provided, that if by such time the TIBOR in respect of such day has not been so published, then the TIBOR for such day will be the TIBOR as published in respect of the first preceding Business Day for which such TIBOR was published thereon; provided further that any TIBOR so determined based on the first preceding Business Day shall be utilized for purposes of calculation of the Eurocurrency Rate for no more than three (3) consecutive Business Days (any such day, collectively, the “TIBOR Lookback Day”);
 
provided that if the Eurocurrency Rate as determined above would be less than the Floor, such rate shall be deemed to be the Floor for purposes of this Agreement. The Eurocurrency Rate for each outstanding Eurocurrency Rate Funding shall be adjusted automatically without notice to the Borrower on and as of the first day of each Interest Period. Determination of the Eurocurrency Rate by the Administrative Agent shall be deemed conclusive absent manifest error.
 
(k)
The definition of “Eurocurrency Rate Lookback Days” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“Eurocurrency Rate Lookback Days” means, collectively, EURIBOR Lookback Day and TIBOR Lookback Day, as applicable, and each such day is a “Eurocurrency Rate Lookback Day”.
 
(l)
The definition of “RFR” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“RFR” means, for any Obligations, interest, fees, commissions or other amounts denominated in, or calculated with respect to, (a) Euro, €STR, (b) Sterling, SONIA, and (c) Yen, TONAR.
 
(m)
Section 2.2 of the Credit Agreement is hereby amended by amending and restating the proviso at the end of the first sentence thereof as follows:
 
provided that all Revolving Advances denominated in Euros and Yen shall be Eurocurrency Rate Advances
 
5
 
(n)
Section 2.12 of the Credit Agreement is hereby amended and restated in its entirety as follows:
 
Section 2.12
Computation of Interest and Fees.
 
All interest on Base Rate Fundings, Daily Simple RFR Fundings accruing based on SONIA and TONAR and Eurocurrency Rate Fundings accruing based on TIBOR will be calculated based on the actual days elapsed in a year of 365 or 366 days, as the case may be. All other interest and all fees hereunder shall be computed on the basis of actual number of days elapsed in a year of 360 days.
 
(o)
Section 2.18(k)(i) of the Credit Agreement is hereby amended by amending and restating the proviso at the end of the first sentence thereof as follows:
 
(i)        Benchmark Replacement.  Notwithstanding anything to the contrary herein or in any other Loan Document and any agreement executed in connection with a Swap Contract shall be deemed not to be a “Loan Document” for purposes of this clause (k), if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to any setting of the then-current Benchmark for any Currency, then (A) if a Benchmark Replacement is determined in accordance with clause (1) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document and (B) if a Benchmark Replacement is determined in accordance with clause (2), (3) or (4) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice from Lenders comprising the Required Lenders of objection to (i) with respect to a Benchmark Replacement determined in accordance with clause (2) or (3) of the definition of “Benchmark Replacement”, the related Benchmark Replacement Adjustment and (ii) with respect to a Benchmark Replacement determined in accordance with clause (4) of the definition of “Benchmark Replacement”, such Benchmark Replacement.
 
2.
Representations and Warranties. The Company hereby represents and warrants that:
 
(a)
This Amendment has been duly executed and delivered by the duly authorized officers of the Company and constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with its respective terms, except to the extent that such enforcement may be limited by bankruptcy, insolvency or similar laws affecting the enforcement of creditors’ rights generally or by general equitable principles.
 
6
 
(b)
Both immediately before and immediately after giving effect to this Amendment, the representations and warranties contained in Article IV of the Credit Agreement are correct in all material respects (or correct in all respects, if any such representation and warranty is qualified by materiality or reference to Material Adverse Change), except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties are correct in all material respects (or correct in all respects, if any such representation and warranty is qualified by materiality or reference to Material Adverse Change) as of such earlier date.
 
(c)
Immediately before and immediately after giving effect to this Amendment, no event has occurred and is continuing, or would result from this Amendment, which constitutes a Default or an Event of Default.
 
3.
Effectiveness. This Amendment shall become effective, and the “First Amendment Effective Date” shall be deemed to have occurred, upon the execution and delivery hereof by the Company, the Administrative Agent and each of the Lenders.
 
4.
References, Effect, Etc. Upon the effectiveness of this Amendment, each reference to the Credit Agreement in the Credit Agreement or any other Loan Document shall mean and be a reference to the Credit Agreement as modified by this Amendment. For the avoidance of doubt, this Amendment constitutes a Loan Document.
 
5.
No Waiver. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Administrative Agent or the Lenders, nor constitute a waiver of or consent to any provision of the Credit Agreement or any other Loan Documents executed and/or delivered in connection therewith.
 
6.
Counterparts. This Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or in electronic (i.e., “pdf” or “tif”) format shall be effective as delivery of a manually executed counterpart of this Amendment.
 
7.
Governing Law. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
 
8.
Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
 
7
 
IN WITNESS WHEREOF, the parties hereto have caused their duly authorized signatories to execute and deliver this Amendment as of the date first above written.
 
    
 
SENSIENT TECHNOLOGIES CORPORATION,
 
 
as Company
 
      
  By:
/s/ Adam Vanderleest
 
 
Name: Adam Vanderleest
 
 
Title: VP, Controller & Chief Accounting Officer
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
8
 
    
 
PNC BANK, NATIONAL ASSOCIATION,
 
 
as the Administrative Agent
 
      
  By:
/s/ Joseph A. Vehec
 
 
Name: Joseph A. Vehec
 
 
Title: Senior Vice President
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
9
 
ACCEPTED AND AGREED:
 
    
LENDERS:
PNC BANK, NATIONAL ASSOCIATION,
 
 
as a Lender and an Issuing Bank
 
      
  By:
/s/ Joseph A. Vehec
 
 
Name: Joseph A. Vehec
 
 
Title: Senior Vice President
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
10
 
    
 
BANK OF AMERICA, N.A.,
 
 
as a Lender
 
      
  By:
/s/ Kevin Krug
 
 
Name: Kevin Krug
 
 
Title: Senior Vice President
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
11
 
    
 
WELLS FARGO BANK, NATIONAL ASSOCIATION,
 
 
as a Lender and an Issuing Bank
 
      
  By:
/s/ Alex Mitchell
 
 
Name: Alex Mitchell
 
 
Title: Vice President
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
12
 
    
 
ING BANK N.V., DUBLIN BRANCH,
 
 
as a Lender
 
      
  By:
/s/ Rory Fitzgerald
 
 
Name: Rory Fitzgerald
 
 
Title: Director
 
 
    
  By:
/s/ Sean Hassett
 
 
Name: Sean Hassett
 
 
Title: Director
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
13
 
    
 
CITIBANK, N.A.,
 
 
as a Lender
 
      
  By:
/s/ Megan Hand
 
 
Name: Megan Hand
 
 
Title: Director
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
14
 
    
 
COBANK, ACB,
 
 
as a Lender
 
      
  By:
/s/ Jasmeet Minhas
 
 
Name: Jasmeet Minhas
 
 
Title: MD- CABG
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
15
 
    
 
HSBC BANK USA, NATIONAL ASSOCIATION,
 
 
as a Lender
 
      
  By:
/s/ John L. Church
 
 
Name: John L. Church
 
 
Title: Managing Director
 
 
SENSIENT TECHNOLOGIES CORPORATION
FIRST AMENDMENT TO CREDIT AGREEMENT
 
 
16
EXHIBIT 31
 
CERTIFICATION
Pursuant to Rule 13a-14(a) of the Exchange Act
 
I, Paul Manning, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Sensient Technologies Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
 
a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:
October 30, 2026
 
/s/ Paul Manning
 
Paul Manning, Chairman, President &
Chief Executive Officer
 
1
 
EXHIBIT 31
 
CERTIFICATION
Pursuant to Rule 13a-14(a) of the Exchange Act
 
I, Tobin Tornehl, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Sensient Technologies Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
 
a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:
October 30, 2026
 
/s/ Tobin Tornehl
 
Tobin Tornehl, Vice President &
Chief Financial Officer
 
 
EXHIBIT 32
 
CERTIFICATION
Pursuant to 18 United States Code § 1350
 
The undersigned hereby certifies that the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026, of Sensient Technologies Corporation (the “Company”) filed with the Securities and Exchange Commission on or about the date hereof fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ Paul Manning
 
 
Name:
Paul Manning
 
Title:
Chairman, President & Chief Executive Officer
 
Date:
October 30, 2026
 
A signed original of this written statement required by Section 906 has been provided to Sensient Technologies Corporation and will be retained by Sensient Technologies Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
1
 
 
EXHIBIT 32
 
CERTIFICATION
Pursuant to 18 United States Code § 1350
 
The undersigned hereby certifies that the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026, of Sensient Technologies Corporation (the “Company”) filed with the Securities and Exchange Commission on or about the date hereof fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
    
 
 
/s/ Tobin Tornehl
 
 
Name:
Tobin Tornehl
 
Title:
Vice President & Chief Financial Officer
 
Date:
October 30, 2026
 
A signed original of this written statement required by Section 906 has been provided to Sensient Technologies Corporation and will be retained by Sensient Technologies Corporation and furnished to the Securities and Exchange Commission or its staff upon request.